Traditional Chinese Medicine Department, The Fourth Hospital of Changsha, Changsha, Hunan, China.
Pharm Biol. 2021 Dec;59(1):811-822. doi: 10.1080/13880209.2021.1941131.
Wutou decoction (WTD) is a Chinese herbal formula alleviating rheumatoid arthritis (RA). SHC adaptor protein 1 (SHC1) regulates apoptosis, inflammation, and the production of reactive oxygen species (ROS). The gene is located near the gene. Bioinformatics analysis showed that the long non-coding RNA LOC101928120 binds to histone deacetylase HDAC1 that might regulate SHC1 expression. The gene might be targeted by the transcriptional factor Aryl hydrocarbon receptor (Ahr).
This study determines the involvement of the Ahr/LOC101928120/SHC1 pathway in WTD alleviation of RA.
Wistar rats were injected with complete Freund's adjuvant in the hind footpad to construe the RA model. WTD (9.8 g/kg/day) was administered intragastrically for 15 days. The CHON-001 chondrocyte cells were treated with IL-1β (10 ng/mL) alone or in combination with WTD (1 μg/mL). A RNA pull-down assay was performed to determine the interaction between LOC101928120 and HDAC1. Ahr targeting the gene was detected using luciferase reporter and chromatin immunoprecipitation assays.
WTD alleviated the swelling of the hind paw in rats with RA and suppressed the chondrocyte apoptosis and ROS production caused by IL-1β. WTD decreased SHC1 but increased LOC101928120 in IL-1β-treated chondrocytes. SHC1 knockdown and LOC101928120 overexpression also showed the protection. However, LOC101928120 knockdown attenuated the protective effects of WTD. WTD stimulated Ahr, which promoted LOC101928120 transcription. LOC101928120 recruited HDAC1 to the promoter region of the gene, thereby decreasing SHC1.
This study revealed a new mechanism by which WTD alleviates RA by modulating the Ahr/LOC101928120/SHC1 pathway.
乌头汤(WTD)是一种缓解类风湿关节炎(RA)的中药配方。衔接蛋白 SHC1 调节细胞凋亡、炎症和活性氧(ROS)的产生。该基因位于附近的基因附近。生物信息学分析表明,长链非编码 RNA LOC101928120 与组蛋白去乙酰化酶 HDAC1 结合,可能调节 SHC1 的表达。该基因可能是转录因子芳香烃受体(Ahr)的靶点。
本研究旨在确定 Ahr/LOC101928120/SHC1 通路在 WTD 缓解 RA 中的作用。
向 Wistar 大鼠后足底注射完全弗氏佐剂构建 RA 模型。WTD(9.8 g/kg/天)灌胃给药 15 天。用白细胞介素-1β(10 ng/mL)单独或联合 WTD(1 μg/mL)处理 CHON-001 软骨细胞。采用 RNA 下拉实验检测 LOC101928120 与 HDAC1 的相互作用。采用荧光素酶报告基因和染色质免疫沉淀实验检测 Ahr 对基因的靶向作用。
WTD 缓解了 RA 大鼠后爪肿胀,并抑制了 IL-1β引起的软骨细胞凋亡和 ROS 产生。WTD 降低了 IL-1β 处理的软骨细胞中的 SHC1,但增加了 LOC101928120。SHC1 敲低和 LOC101928120 过表达也表现出保护作用。然而,LOC101928120 敲低减弱了 WTD 的保护作用。WTD 刺激 Ahr,促进 LOC101928120 转录。LOC101928120 将 HDAC1 募集到基因启动子区域,从而降低 SHC1。
本研究揭示了 WTD 通过调节 Ahr/LOC101928120/SHC1 通路缓解 RA 的新机制。